In vitro susceptibility of Plasmodium falciparum to antimalarial drugs five years after the change for treatment policy of uncomplicated malaria in Burkina Faso

In vitro susceptibility of Plasmodium falciparum to antimalarial drugs five years after the change for treatment policy of uncomplicated malaria in Burkina Faso

Bibliographic Details
Main Authors:	L.N. Bonkian, T. Halidou, V. Innocent, Z. Hato, O. Jean Bosco, G. Tinga Robert
Format:	Article
Language:	English
Published:	Elsevier 2014-04-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S120197121401056X

Similar Items

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
by: Moussa Lingani, et al.
Published: (2020-01-01)

Efficacy of pyrimethamine-sulfadoxine in young children with uncomplicated falciparum malaria in rural Burkina Faso
by: Traore Corneille, et al.
Published: (2004-05-01)

Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso
by: Paul Sondo, et al.
Published: (2020-08-01)

Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated <it>Plasmodium falciparum </it>malaria in Senegal
by: Faye Oumar, et al.
Published: (2007-06-01)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial [version 2; peer review: 2 approved]
by: Sofia Birgersson, et al.
Published: (2020-01-01)

Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso
by: Meissner Peter, et al.
Published: (2008-04-01)

A study of the impact of insecticide-treated curtains on the prevalence of antimalarial drug resistance in children with uncomplicated malaria in Burkina Faso
by: Diallo, Diadier Amadou
Published: (2005)

Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
by: Steffen Borrmann, et al.
Published: (2008-11-01)

Transplacental Transmission of Plasmodium falciparum in a Highly Malaria Endemic Area of Burkina Faso
by: Alphonse Ouédraogo, et al.
Published: (2012-01-01)

The plasticity of <it>Plasmodium falciparum </it>gametocytaemia in relation to age in Burkina Faso
by: Drakeley Chris, et al.
Published: (2010-10-01)

Haemoglobin variants and <it>Plasmodium falciparum</it> malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso
by: Bougouma Edith C, et al.
Published: (2012-05-01)

Altered Ex-Vivo Cytokine Responses in Children With Asymptomatic Plasmodium falciparum Infection in Burkina Faso: An Additional Argument to Treat Asymptomatic Malaria?
by: Annelies Post, et al.
Published: (2021-06-01)

Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]
by: Walter-Sack Ingeborg, et al.
Published: (2005-09-01)

Human Gene Expression in Uncomplicated Plasmodium falciparum Malaria
by: James M. Colborn, et al.
Published: (2015-01-01)

Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso
by: Koné Bibiane, et al.
Published: (2006-06-01)

Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children
by: Kamya Moses R, et al.
Published: (2008-06-01)

Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
by: Stepniewska Kasia, et al.
Published: (2006-12-01)

Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
by: Augustin Zoungrana, et al.
Published: (2008-02-01)

<it>Plasmodium falciparum </it>genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso
by: Konaté Amadou T, et al.
Published: (2009-06-01)

Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis
by: The WorldWide Antimalarial Resistance Network Methodology Study Group
Published: (2019-07-01)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
by: Prakash Ghimire, et al.
Published: (2018-08-01)

Artemisinin-based combination therapy for uncomplicated <it>Plasmodium falciparum </it>malaria in Colombia
by: Taylor Walter RJ, et al.
Published: (2007-02-01)

Artemether&ndash;lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
by: Stephan Ehrhardt, et al.
Published: (2009-10-01)

Monitoring the Response of Plasmodium vivax to Chloroquine and Uncomplicated P. falciparum to Artesunate-fansidar Antimalarials in Southeastern Iran
by: Hamid AZARIAN MOGHADAM, et al.
Published: (2018-03-01)

Malaria resistance genes are associated with the levels of IgG subclasses directed against <it>Plasmodium falciparum</it> blood-stage antigens in Burkina Faso
by: Afridi Sarwat, et al.
Published: (2012-09-01)

Genetic profiling of the Plasmodium falciparum parasite population in uncomplicated malaria from India
by: Amit Kumar, et al.
Published: (2019-12-01)

Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan
by: Ahmed Elderderi S, et al.
Published: (2005-09-01)

Clinically uncomplicated <it>Plasmodium falciparum </it>malaria with high schizontaemia: A case report
by: Ashley Elizabeth A, et al.
Published: (2008-04-01)

Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
by: Florian Kurth, et al.
Published: (2016-08-01)

Plasmodium falciparum msp1 and msp2 genetic diversity and allele frequencies in parasites isolated from symptomatic malaria patients in Bobo-Dioulasso, Burkina Faso
by: Anyirékun Fabrice Somé, et al.
Published: (2018-05-01)

Efficacy of antimalarial drugs for treatment of uncomplicated falciparum malaria in Asian region: A network meta-analysis.
by: Cho Naing, et al.
Published: (2019-01-01)

Asymptomatic malaria and anaemia among pregnant women during high and low malaria transmission seasons in Burkina Faso: household-based cross-sectional surveys in Burkina Faso, 2013 and 2017
by: Toussaint Rouamba, et al.
Published: (2021-05-01)

Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates
by: Jersley D. Chirawurah, et al.
Published: (2017-12-01)

Serine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets
by: Asrar Alam
Published: (2014-01-01)

Epidemic of Plasmodium falciparum Malaria Involving Substandard Antimalarial Drugs, Pakistan, 2003
by: Toby Leslie, et al.
Published: (2009-11-01)

Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso
by: Hamatandi Magloire Natama, et al.
Published: (2021-02-01)

Falciparum malaria in young children of rural Burkina Faso: comparison of survey data in 1999 with 2009
by: Coulibaly Boubacar, et al.
Published: (2011-10-01)

In vitro susceptibility of Indian Plasmodium falciparum isolates to different antimalarial drugs & antibiotics
by: Pooja Agarwal, et al.
Published: (2017-01-01)

Genetic diversity of Plasmodium falciparum and genetic profile in children affected by uncomplicated malaria in Cameroon
by: Theresia Njuabe Metoh, et al.
Published: (2020-03-01)

Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated <it>Plasmodium falciparum </it>malaria
by: Quezada Wilmer, et al.
Published: (2009-04-01)

Cannot write session to /tmp/vufind_sessions/sess_5j2pcrb2510nn6l2jg1h1ud7a5